5.8 C
London
Thursday, March 28, 2024
HomeBusinessEMVision: Recommences clinical trial enrolment

EMVision: Recommences clinical trial enrolment

Date:

EMVision: Recommences clinical trial enrolment

  • Medical imaging company EMVision has recommenced enrolling patients in its clinical study at Brisbane’s Princess Alexandra Hospital
  • The study is testing EMV’s portable brain imaging device in stroke patients
  • The company also says it is continuing to monitor the COVID-19 situation, and any associated impacts on its trial work
  • This includes access to clinical facilities and personnel which may diverted due to pandemic-related public health needs
  • EMVision says it will continue to provide updates to the market as the situation progresses and further clinical milestones reached
  • EMVision is down 2.7 per cent to 89 cents per share as at 12 pm AEST

Related stories

BNY Mellon deploys AI supercomputer from Nvidia

BNY Mellon, a US-based banking heavyweight, has deployed...

Colombian BNPL firm Addi lands $86m in equity and debt funding

Colombian buy now, pay later (BNPL) firm Addi...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

spot_img